Showing results (71-80 of 104) with videos related to

Sort By:
Pageof 11
Annals of Hematology|March 28, 2025
A phase 1 study of durvalumab as monotherapy or combined with tremelimumab with or without azacitidine in patients with myelodysplastic syndromeGuillermo Garcia-Manero, Manila Gaddh, Uwe Platzbecker, et al.
Blood|November 1, 2014
GATA2 deficiency-associated bone marrow disorder differs from idiopathic aplastic anemiaKarthik A Ganapathi, Danielle M Townsley, Amy P Hsu, et al.
Hepatology (Baltimore, Md.)|February 22, 2019
The Spectrum of Hepatic Involvement in Patients With Telomere DiseaseDevika Kapuria, Gil Ben-Yakov, Rebecca Ortolano, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 15, 2016
Memory Stem T Cells in Autoimmune Disease: High Frequency of Circulating CD8+ Memory Stem Cells in Acquired Aplastic AnemiaKohei Hosokawa, Pawel Muranski, Xingmin Feng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 21, 2020
Safety and Clinical Activity of MEDI0562, a Humanized OX40 Agonist Monoclonal Antibody, in Adult Patients with Advanced Solid TumorsBonnie S Glisson, Rom S Leidner, Robert L Ferris, et al.
British Journal of Haematology|July 20, 2016
Epigenetic landscape of the TERT promoter: a potential biomarker for high risk AML/MDSXin Zhao, Xin Tian, Sachiko Kajigaya, et al.
The New England Journal of Medicine|April 20, 2017
Eltrombopag Added to Standard Immunosuppression for Aplastic AnemiaDanielle M Townsley, Phillip Scheinberg, Thomas Winkler, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 8, 2018
Pathogenic TERT promoter variants in telomere diseasesFernanda Gutierrez-Rodrigues, Flávia S Donaires, André Pinto, et al.
The New England Journal of Medicine|May 19, 2016
Danazol Treatment for Telomere DiseasesDanielle M Townsley, Bogdan Dumitriu, Delong Liu, et al.
Pageof 11